173 related articles for article (PubMed ID: 30576845)
1. Type I and II interferons commit to abnormal expression of chemokine receptor on B cells in patients with systemic lupus erythematosus.
Yoshikawa M; Nakayamada S; Kubo S; Nawata A; Kitanaga Y; Iwata S; Sakata K; Ma X; Wang SP; Nakano K; Saito K; Tanaka Y
Clin Immunol; 2019 Mar; 200():1-9. PubMed ID: 30576845
[TBL] [Abstract][Full Text] [Related]
2. PD-1+CXCR5-CD4+T cells are correlated with the severity of systemic lupus erythematosus.
Lin J; Yu Y; Ma J; Ren C; Chen W
Rheumatology (Oxford); 2019 Dec; 58(12):2188-2192. PubMed ID: 31180450
[TBL] [Abstract][Full Text] [Related]
3. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
Henneken M; Dörner T; Burmester GR; Berek C
Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
[TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus.
Eriksson C; Eneslätt K; Ivanoff J; Rantapää-Dahlqvist S; Sundqvist KG
Lupus; 2003; 12(10):766-74. PubMed ID: 14596426
[TBL] [Abstract][Full Text] [Related]
6. Associations of circulating CXCR3
Han L; Yang X; Yu Y; Wan W; Lv L; Zou H
Mod Rheumatol; 2019 May; 29(3):461-469. PubMed ID: 29694256
[TBL] [Abstract][Full Text] [Related]
7. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
[TBL] [Abstract][Full Text] [Related]
8. Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility.
Aue A; Szelinski F; Weißenberg SY; Wiedemann A; Rose T; Lino AC; Dörner T
Rheumatology (Oxford); 2020 Nov; 59(11):3435-3442. PubMed ID: 32357246
[TBL] [Abstract][Full Text] [Related]
9. Circulating TFH subset distribution is strongly affected in lupus patients with an active disease.
Le Coz C; Joublin A; Pasquali JL; Korganow AS; Dumortier H; Monneaux F
PLoS One; 2013; 8(9):e75319. PubMed ID: 24069401
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory chemokine profiles and their correlations with effector CD4 T cell and regulatory cell subpopulations in cutaneous lupus erythematosus.
Méndez-Flores S; Hernández-Molina G; Azamar-Llamas D; Zúñiga J; Romero-Díaz J; Furuzawa-Carballeda J
Cytokine; 2019 Jul; 119():95-112. PubMed ID: 30903869
[TBL] [Abstract][Full Text] [Related]
11. The role of T helper cell subsets in pathogenesis of Systemic Lupus Erythematosus and their relation to disease activity.
Al-Saleh J; el-Eissawy S
Egypt J Immunol; 2006; 13(2):41-8. PubMed ID: 18689270
[TBL] [Abstract][Full Text] [Related]
12. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients.
Enghard P; Humrich JY; Rudolph B; Rosenberger S; Biesen R; Kuhn A; Manz R; Hiepe F; Radbruch A; Burmester GR; Riemekasten G
Arthritis Rheum; 2009 Jan; 60(1):199-206. PubMed ID: 19116922
[TBL] [Abstract][Full Text] [Related]
13. IL-21 dependent Granzyme B production of B-cells is decreased in patients with lupus nephritis.
Rabani M; Wilde B; Hübbers K; Xu S; Kribben A; Witzke O; Dolff S
Clin Immunol; 2018 Mar; 188():45-51. PubMed ID: 29274388
[TBL] [Abstract][Full Text] [Related]
14. Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells.
Muehlinghaus G; Cigliano L; Huehn S; Peddinghaus A; Leyendeckers H; Hauser AE; Hiepe F; Radbruch A; Arce S; Manz RA
Blood; 2005 May; 105(10):3965-71. PubMed ID: 15687242
[TBL] [Abstract][Full Text] [Related]
15. Plasmablast-like Phenotype Among Antigen-Experienced CXCR5-CD19
Szelinski F; Stefanski AL; Schrezenmeier E; Rincon-Arevalo H; Wiedemann A; Reiter K; Ritter J; Lettau M; Dang VD; Fuchs S; Frei AP; Alexander T; Lino AC; Dörner T
Arthritis Rheumatol; 2022 Sep; 74(9):1556-1568. PubMed ID: 35507291
[TBL] [Abstract][Full Text] [Related]
16. Striking alteration of some populations of T/B cells in systemic lupus erythematosus: relationship to expression of CD62L or some chemokine receptors.
Watanabe T; Suzuki J; Mitsuo A; Nakano S; Tamayama Y; Katagiri A; Amano H; Morimoto S; Tokano Y; Takasaki Y
Lupus; 2008 Jan; 17(1):26-33. PubMed ID: 18089680
[TBL] [Abstract][Full Text] [Related]
17. CXCR5 is critically involved in progression of lupus through regulation of B cell and double-negative T cell trafficking.
Wiener A; Schippers A; Wagner N; Tacke F; Ostendorf T; Honke N; Tenbrock K; Ohl K
Clin Exp Immunol; 2016 Jul; 185(1):22-32. PubMed ID: 26990531
[TBL] [Abstract][Full Text] [Related]
18. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
[TBL] [Abstract][Full Text] [Related]
19. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
[TBL] [Abstract][Full Text] [Related]
20. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
